Lung Cancer

1

PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma

Cooper, Wendy A., Tran, Thang, Vilain, Ricardo E., Madore, Jason, Selinger, Christina I., Kohonen-Corish, Maija, Yip, PoYee, Yu, Bing, O’Toole, Sandra A., McCaughan, Brian C., Yearley, Jennifer H., Ho

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 408 KB

english, 2015

2

A family history of cancer and lung cancer risk in never-smokers: A clinic-based case–control study

Lin, Huan, Huang, Yi-Sheng, Yan, Hong-hong, Yang, Xue-Ning, Zhong, Wen-Zhao, Ye, Huan-Wen, Yang, Jin-Ji, Zhou, Qing, Wu, Yi-Long

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 184 KB

english, 2015

3

Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended

Savic, Spasenija, Diebold, Joachim, Zimmermann, Anne-Katrin, Jochum, Wolfram, Baschiera, Betty, Grieshaber, Susanne, Tornillo, Luigi, Bisig, Bettina, Kerr, Keith, Bubendorf, Lukas

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.04 MB

english, 2015

4

Could less be more?—A systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patient selection

Cao, Christopher, Chandrakumar, David, Gupta, Sunil, Yan, Tristan D., Tian, David H.

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.07 MB

english, 2015

5

Rehabilitation in patients with radically treated respiratory cancer: A randomised controlled trial comparing two training modalities

Salhi, Bihiyga, Haenebalcke, Christel, Perez-Bogerd, Silvia, Nguyen, Mai D., Ninane, Vincent, Malfait, Thomas L.A., Vermaelen, Karim Y., Surmont, Veerle F., Van Maele, Georges, Colman, Roos, Derom, Er

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.17 MB

english, 2015

6

Lung cancer at the intensive care unit: The era of targeted therapy

Adam, Valerie, Dooms, Christophe, Vansteenkiste, Johan

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.02 MB

english, 2015

7

Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England

Damhuis, R.A., Khakwani, A., De Schutter, H., Rich, A.L., Burgers, J.A., van Meerbeeck, J.P.

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 503 KB

english, 2015

8

Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma

Vigouroux, Charlène, Casse, Jean-Matthieu, Battaglia-Hsu, Shyue-Fang, Brochin, Lydia, Luc, Amandine, Paris, Christophe, Lacomme, Stéphanie, Gueant, Jean-Louis, Vignaud, Jean-Michel, Gauchotte, Guillau

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 2.89 MB

english, 2015

9

Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer

Lal, R., Hillerdal, G.N., Shah, R.N.H., Crosse, B., Thompson, J., Nicolson, M., Vikström, A., Potter, V.A., Visseren-Grul, C., Lorenzo, M., D’yachkova, Y., Bourayou, N., Summers, Y.J.

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 676 KB

english, 2015

10

Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer

Kang, Nahyeon, Choi, Su Yeon, Kim, Young Kyoon, Yoo, Ie Ryung, Han, Dae Hee, Lee, Dong Soo, Kim, Yeon Sil, Hong, Sook Hee, Kang, Jin Hyoung, Lee, Kyo Young, Park, Jae Kil, Sung, Sook Whan, Park, Mi Su

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.02 MB

english, 2015

11

Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting

Sassier, Marion, Dugué, Audrey Emmanuelle, Clarisse, Bénédicte, Lesueur, Paul, Avrillon, Virginie, Bizieux-Thaminy, Acya, Auliac, Jean-Bernard, Kaluzinski, Laure, Tillon, Julie, Robinet, Gilles, Le Ca

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 705 KB

english, 2015

12

SABR for aggressive local therapy of metastatic cancer: A new paradigm for metastatic non-small cell lung cancer

Westover, Kenneth D., Iyengar, Puneeth, Sharma, Akanksha Neeraj, Timmerman, Robert

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.63 MB

english, 2015

13

A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110)

Nishino, Kazumi, Imamura, Fumio, Kumagai, Toru, Katakami, Nobuyuki, Hata, Akito, Okuda, Chiyuki, Urata, Yoshiko, Hattori, Yosihihiro, Tachihara, Motoko, Yokota, Souichirou, Nishimura, Takashi, Kaneda,

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.00 MB

english, 2015

14

Racial disparities in the use of SBRT for treating early-stage lung cancer

Corso, Christopher D., Park, Henry S., Kim, Anthony W., Yu, James B., Husain, Zain, Decker, Roy H.

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 600 KB

english, 2015

15

The incidence and clinical impact of bone metastases in non-small cell lung cancer

Kuchuk, Michael, Kuchuk, Iryna, Sabri, Elham, Hutton, Brian, Clemons, Mark, Wheatley-Price, Paul

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.21 MB

english, 2015

16

Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study)

Moro-Sibilot, Denis, Audigier-Valette, Clarisse, Merle, Patrick, Quoix, Elisabeth, Souquet, Pierre-Jean, Barlesi, Fabrice, Chouaid, Christos, Molinier, Olivier, Bennouna, Jaafar, Lavolé, Armelle, Mazi

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 662 KB

english, 2015

17

Research priorities in mesothelioma: A James Lind Alliance Priority Setting Partnership

Stephens, R.J., Whiting, C., Cowan, K.

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 601 KB

english, 2015

18

The impact of clinical characteristics on outcomes from maintenance therapy in non-small cell lung cancer: A systematic review with meta-analysis

Zhou, Fei, Jiang, Tao, Ma, Wanrong, Gao, Guanghui, Chen, Xiaoxia, Zhou, Caicun

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 1.82 MB

english, 2015

19

FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer

Kohutek, Zachary A., Wu, Abraham J., Zhang, Zhigang, Foster, Amanda, Din, Shaun U., Yorke, Ellen D., Downey, Robert, Rosenzweig, Kenneth E., Weber, Wolfgang A., Rimner, Andreas

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 611 KB

english, 2015

20

Editorial Board

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 67 KB

english, 2015

21

Corrigendum to “High resolution CT in differentiating minimally invasive component in early lung adenocarcinoma” [Lung Cancer 84 (2014) 236–241]

Zhang, Yu, Qiang, Jin Wei, Ye, Jian Ding, Ye, Xiao Dan, Zhang, Jie

Journal:

Lung Cancer

Year:

2015

Language:

english

File:

PDF, 121 KB

english, 2015

22

Volume 89; Issue 2

PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma

A family history of cancer and lung cancer risk in never-smokers: A clinic-based case–control study

Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended

Could less be more?—A systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patient selection

Rehabilitation in patients with radically treated respiratory cancer: A randomised controlled trial comparing two training modalities

Lung cancer at the intensive care unit: The era of targeted therapy

Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England

Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma

Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer

Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer

Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting

SABR for aggressive local therapy of metastatic cancer: A new paradigm for metastatic non-small cell lung cancer

A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110)

Racial disparities in the use of SBRT for treating early-stage lung cancer

The incidence and clinical impact of bone metastases in non-small cell lung cancer

Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study)

Research priorities in mesothelioma: A James Lind Alliance Priority Setting Partnership

The impact of clinical characteristics on outcomes from maintenance therapy in non-small cell lung cancer: A systematic review with meta-analysis

FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer

Editorial Board

Corrigendum to “High resolution CT in differentiating minimally invasive component in early lung adenocarcinoma” [Lung Cancer 84 (2014) 236–241]

Contents